Details
| Stereochemistry | UNKNOWN |
| Molecular Formula | C60H88N2O19 |
| Molecular Weight | 1141.3427 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 19 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC1=CC=C(C=C1)C(=O)CC(O)CCC(C)C2OC(=O)CC(O)CC(=O)CC(O)CC(O)CC(O)CC(O)CC3(O)CC(O)C(C(CC(O[C@H]4O[C@@H](C)[C@H](O)[C@@H](N)[C@H]4O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\C2C)O3)C(=O)OC
InChI
InChIKey=GVEVTKSEPQUIJA-BXMMMMRLSA-N
InChI=1S/C60H88N2O19/c1-36-18-16-14-12-10-8-6-7-9-11-13-15-17-19-48(79-59-56(74)54(61)55(73)38(3)78-59)33-51-53(58(75)77-5)50(71)35-60(76,81-51)34-47(69)30-45(67)28-43(65)26-42(64)27-44(66)29-46(68)32-52(72)80-57(36)37(2)20-25-41(63)31-49(70)39-21-23-40(62-4)24-22-39/h6-19,21-24,36-38,41-43,45-48,50-51,53-57,59,62-65,67-69,71,73-74,76H,20,25-35,61H2,1-5H3/b7-6+,10-8+,11-9+,14-12+,15-13+,18-16+,19-17+/t36?,37?,38-,41?,42?,43?,45?,46?,47?,48?,50?,51?,53?,54+,55-,56+,57?,59+,60?/m0/s1
| Molecular Formula | C60H88N2O19 |
| Molecular Weight | 1141.3427 |
| Charge | 0 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 5 / 19 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Long-term therapy of benign prostatic hyperplasia. Our experience]. | 2001 Mar |
|
| [Mepartricine and prostatitis. Clinical experience and rationale for use]. | 2001 Sep |
|
| Role of mepartricin in category III chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized prospective placebo-controlled trial. | 2004 Jan |
|
| Effects of mepartricin, a polyene macrolide antibiotic, on estrogen-induced hyperplastic growth of the dorsolateral prostate and seminal vesicle in immature castrated rats. | 2005 |
|
| Antifungal chemical compounds identified using a C. elegans pathogenicity assay. | 2007 Feb |
|
| Chronic prostatitis. | 2008 May 22 |
|
| Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay. | 2009 Sep 14 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 00:30:50 GMT 2023
by
admin
on
Sat Dec 16 00:30:50 GMT 2023
|
| Record UNII |
L13V8793FQ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
263-584-8
Created by
admin on Sat Dec 16 00:30:50 GMT 2023 , Edited by admin on Sat Dec 16 00:30:50 GMT 2023
|
PRIMARY | |||
|
m7184
Created by
admin on Sat Dec 16 00:30:50 GMT 2023 , Edited by admin on Sat Dec 16 00:30:50 GMT 2023
|
PRIMARY | Merck Index | ||
|
L13V8793FQ
Created by
admin on Sat Dec 16 00:30:50 GMT 2023 , Edited by admin on Sat Dec 16 00:30:50 GMT 2023
|
PRIMARY | |||
|
DTXSID40872304
Created by
admin on Sat Dec 16 00:30:50 GMT 2023 , Edited by admin on Sat Dec 16 00:30:50 GMT 2023
|
PRIMARY | |||
|
62534-68-3
Created by
admin on Sat Dec 16 00:30:50 GMT 2023 , Edited by admin on Sat Dec 16 00:30:50 GMT 2023
|
PRIMARY | |||
|
76969110
Created by
admin on Sat Dec 16 00:30:50 GMT 2023 , Edited by admin on Sat Dec 16 00:30:50 GMT 2023
|
PRIMARY |